Stifel Nicolaus Cuts American Well (NYSE:AMWL) Price Target to $5.00

American Well (NYSE:AMWL) had its target price lowered by Stifel Nicolaus from $6.00 to $5.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a hold rating on the stock.

Several other research analysts have also commented on AMWL. Wall Street Zen lowered American Well from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of American Well in a research note on Wednesday, January 21st. Morgan Stanley cut their target price on American Well from $10.50 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 18th. Finally, Wells Fargo & Company decreased their price target on American Well from $12.00 to $9.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, American Well presently has a consensus rating of “Hold” and an average target price of $7.42.

American Well Stock Performance

Shares of AMWL opened at $5.38 on Friday. The stock has a market capitalization of $87.99 million, a PE ratio of -0.90 and a beta of 1.36. The company’s fifty day moving average is $4.68 and its 200 day moving average is $5.44. American Well has a fifty-two week low of $3.71 and a fifty-two week high of $12.95.

American Well (NYSE:AMWL) last released its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) EPS for the quarter, beating the consensus estimate of ($1.59) by $0.07. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. The business had revenue of $55.31 million during the quarter, compared to analyst estimates of $52.71 million. As a group, research analysts forecast that American Well will post -9.34 earnings per share for the current year.

Insider Buying and Selling at American Well

In related news, insider Dmitry Zamansky sold 6,243 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $4.85, for a total transaction of $30,278.55. Following the completion of the transaction, the insider owned 191,468 shares in the company, valued at $928,619.80. The trade was a 3.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 14,633 shares of company stock valued at $67,972 in the last quarter. Corporate insiders own 12.80% of the company’s stock.

Institutional Trading of American Well

Several institutional investors and hedge funds have recently made changes to their positions in AMWL. Corton Capital Inc. boosted its stake in shares of American Well by 71.7% during the second quarter. Corton Capital Inc. now owns 27,402 shares of the company’s stock valued at $244,000 after purchasing an additional 11,445 shares during the period. Monaco Asset Management SAM bought a new stake in American Well during the 4th quarter valued at about $338,000. Prelude Capital Management LLC purchased a new stake in American Well in the 3rd quarter valued at about $86,000. Two Sigma Investments LP grew its stake in American Well by 22.6% in the 3rd quarter. Two Sigma Investments LP now owns 46,329 shares of the company’s stock worth $285,000 after acquiring an additional 8,553 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new position in shares of American Well during the second quarter worth approximately $39,000. 56.05% of the stock is currently owned by institutional investors.

American Well News Roundup

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Q4 results beat consensus: AMWL reported ($1.52) EPS vs. consensus ($1.59) and revenue of $55.31M vs. $52.71M expected — a modest beat that suggests underlying demand. Read More.
• Neutral Sentiment: Earnings call and transcript available; analysts and media are parsing commentary for signs of margin improvement and CAC trends. Read More.
• Neutral Sentiment: Independent write-ups (Zacks, Benzinga) provide metric-by-metric comparisons to estimates and discuss where growth drivers and cost levers may lie. Read More.
• Negative Sentiment: Guidance materially below Street expectations: Q1 revenue guide of $48.0M–$53.0M vs. consensus ~$59.9M, and FY2026 revenue guide of $195M–$205M vs. consensus ~$243.5M — the guidance shortfall is the clearest near-term driver of downward pressure on the stock. Read More.
• Negative Sentiment: Analyst action: Stifel cut its price target to $5.00 and moved to a “hold” — about a 7% downside from the current ~$5.38 level — reinforcing cautious sentiment after the outlook miss. Read More.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.